Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Viscosupplementation Market, by Application
1.4.2 North America Viscosupplementation Market, by Product
1.4.3 North America Viscosupplementation Market, by End-use
1.4.4 North America Viscosupplementation Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. North America Viscosupplementation Market by Application
4.1 North America Knee Osteoarthritis Market by Country
4.2 North America Hand Osteoarthritis Market by Country
4.3 North America Hip Osteoarthritis Market by Country
4.4 North America Others Market by Country
Chapter 5. North America Viscosupplementation Market by Product
5.1 North America Three Injection Market by Country
5.2 North America Single Injection Market by Country
5.3 North America Five Injection Market by Country
Chapter 6. North America Viscosupplementation Market by End-use
6.1 North America Hospitals Market by Country
6.2 North America Orthopedic Clinics/ASCs Market by Country
Chapter 7. North America Viscosupplementation Market by Country
7.1 US Viscosupplementation Market
7.1.1 US Viscosupplementation Market by Application
7.1.2 US Viscosupplementation Market by Product
7.1.3 US Viscosupplementation Market by End-use
7.2 Canada Viscosupplementation Market
7.2.1 Canada Viscosupplementation Market by Application
7.2.2 Canada Viscosupplementation Market by Product
7.2.3 Canada Viscosupplementation Market by End-use
7.3 Mexico Viscosupplementation Market
7.3.1 Mexico Viscosupplementation Market by Application
7.3.2 Mexico Viscosupplementation Market by Product
7.3.3 Mexico Viscosupplementation Market by End-use
7.4 Rest of North America Viscosupplementation Market
7.4.1 Rest of North America Viscosupplementation Market by Application
7.4.2 Rest of North America Viscosupplementation Market by Product
7.4.3 Rest of North America Viscosupplementation Market by End-use
Chapter 8. Company Profiles
8.1 DePuy Synthes (Johnson & Johnson)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental & Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Sanofi S.A.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Zimmer Biomet Holdings, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Ferring Holdings SA
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research and Development Expense
8.4.5 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 LG Chem Ltd. (LG Corporation)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 SWOT Analysis
8.7 Anika Therapeutics, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Smith & Nephew PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional and Segmental Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Seikagaku Corp.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis
Unique Offerings 